NO20022973L - Oksazolidinoner som har en sulfoksiminfunksjonalitet - Google Patents

Oksazolidinoner som har en sulfoksiminfunksjonalitet

Info

Publication number
NO20022973L
NO20022973L NO20022973A NO20022973A NO20022973L NO 20022973 L NO20022973 L NO 20022973L NO 20022973 A NO20022973 A NO 20022973A NO 20022973 A NO20022973 A NO 20022973A NO 20022973 L NO20022973 L NO 20022973L
Authority
NO
Norway
Prior art keywords
oxazolidinones
sulfoximine
functionality
sulfoximine functionality
Prior art date
Application number
NO20022973A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022973D0 (no
Inventor
Jr Jackson B Hester
David L Alexander
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022973D0 publication Critical patent/NO20022973D0/no
Publication of NO20022973L publication Critical patent/NO20022973L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022973A 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet NO20022973L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17191699P 1999-12-21 1999-12-21
PCT/US2000/032451 WO2001046185A1 (en) 1999-12-21 2000-12-12 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents

Publications (2)

Publication Number Publication Date
NO20022973D0 NO20022973D0 (no) 2002-06-20
NO20022973L true NO20022973L (no) 2002-08-20

Family

ID=22625632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022973A NO20022973L (no) 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet

Country Status (22)

Country Link
US (1) US20010046987A1 (pl)
EP (1) EP1242417A1 (pl)
JP (1) JP2003518117A (pl)
KR (1) KR20020067557A (pl)
CN (1) CN1221548C (pl)
AR (1) AR029211A1 (pl)
AU (1) AU782078B2 (pl)
BR (1) BR0016605A (pl)
CA (1) CA2389482A1 (pl)
CO (1) CO5251427A1 (pl)
CZ (1) CZ20022142A3 (pl)
EA (1) EA005567B1 (pl)
HU (1) HUP0203869A2 (pl)
IL (1) IL150348A0 (pl)
MX (1) MXPA02006233A (pl)
NO (1) NO20022973L (pl)
NZ (1) NZ519725A (pl)
PE (1) PE20010931A1 (pl)
PL (1) PL356478A1 (pl)
SK (1) SK7572002A3 (pl)
WO (1) WO2001046185A1 (pl)
ZA (1) ZA200204166B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
EP1385844B1 (en) * 2001-04-07 2006-07-05 Astrazeneca AB Oxazolidinones containing a sulfonimid group as antibiotics
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108794D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA05010783A (es) 2003-04-09 2005-12-12 Pharmacia & Upjohn Co Llc Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
JP2008521792A (ja) * 2004-11-29 2008-06-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌薬としてのジアゼピンオキサゾリジノン
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
EP1899331B1 (en) 2005-06-29 2009-11-25 Pharmacia & Upjohn Company LLC Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
RU2429236C2 (ru) 2005-10-04 2011-09-20 Байер Шеринг Фарма Акциенгезельшафт Новая полиморфная форма и аморфная форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)-фенил]-1, 3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
NZ295528A (en) * 1994-11-15 1999-03-29 Upjohn Co Bicyclic oxazine and thiazine oxazolidinone antibacterials
WO1997009328A1 (en) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
BR9815518A (pt) * 1997-05-30 2000-11-21 Upjohn Co Agentes antibacterianos de oxazolidinona tendo funcionalidade de tiocarbonila

Also Published As

Publication number Publication date
IL150348A0 (en) 2002-12-01
EP1242417A1 (en) 2002-09-25
NO20022973D0 (no) 2002-06-20
AU782078B2 (en) 2005-06-30
MXPA02006233A (es) 2002-12-05
PL356478A1 (pl) 2004-06-28
CO5251427A1 (es) 2003-02-28
NZ519725A (en) 2004-05-28
KR20020067557A (ko) 2002-08-22
WO2001046185A1 (en) 2001-06-28
AU2050201A (en) 2001-07-03
EA200200699A1 (ru) 2003-02-27
EA005567B1 (ru) 2005-04-28
SK7572002A3 (en) 2002-12-03
CN1221548C (zh) 2005-10-05
US20010046987A1 (en) 2001-11-29
PE20010931A1 (es) 2001-08-29
CN1391572A (zh) 2003-01-15
AR029211A1 (es) 2003-06-18
HUP0203869A2 (hu) 2003-07-28
CA2389482A1 (en) 2001-06-28
JP2003518117A (ja) 2003-06-03
ZA200204166B (en) 2003-10-29
CZ20022142A3 (cs) 2002-11-13
BR0016605A (pt) 2003-02-25

Similar Documents

Publication Publication Date Title
NO20022973D0 (no) Oksazolidinoner som har en sulfoksiminfunksjonalitet
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
IT1318317B1 (it) Dispensatore a doppia funzione
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
DE50007817D1 (de) Mikrospiegel
NL1014872A1 (nl) Aandrijving.
NO20000693D0 (no) Festeanordning
NO20015078D0 (no) Sulfonamidderivater som har oksadiazolringer
NO20041165L (no) Avstengningsanordning.
DK1026405T3 (da) Fastgørelsesanordning
BR0101990B1 (pt) dispositivo elÁstico de suspensço de uma estrutura vibratària em uma estrutura rÍgida.
ITTO20030241A1 (it) Albero a camme.
IT1318923B1 (it) Pompa a doppia membrana - compatta
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
NO20041455L (no) Zirkonium-/metalloksidfibrer.
DE60208495D1 (de) Kontrastphantom
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
DE60111415D1 (de) Nagelschneider
DE50010321D1 (de) Emulgatoren
IT1317768B1 (it) Disposizione di azionamento con un dispositivo di regolazione.
FR2802198B1 (fr) Machine a sections individuelles
DE502004004887D1 (de) Zangenaggregat einer kämmaschine
IT1318610B1 (it) Micomelanine a struttura polinaftoica.
DE50004387D1 (de) Schliessvorrichtung
DE59912578D1 (de) Turbomaschinenschaufel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application